Vizimpro\u00a0<\/b><\/strong>Co-Development\u00a0<\/b><\/strong>With Pfizer<\/b><\/strong><\/h2>\n<\/div>\n<\/div>\n<\/div>\n[\/vc_column_text][vc_empty_space height=”20px”][vc_column_text]In 2012, SFJ began a partnership with Pfizer for the funding, design, and execution of a 452-patient global Phase 3 trial of dacomitinib (Vizimpro), a first line therapy for EGFR-mutated non small cell lung cancer. Upon the success of the trial, this once-daily oral medication received regulatory approvals globally between December 2018 and May 2019.[\/vc_column_text][vc_empty_space height=”40px”][vc_column_text]<\/p>\n
Process Highlights For This Global Registration Trial:<\/strong><\/h3>\n[\/vc_column_text][vc_empty_space height=”20px”][vc_column_text css=”.vc_custom_1625212670985{padding-left: 20px !important;}”]<\/p>\n
\n- SFJ and Pfizer agreed basic study design parameters<\/li>\n
- SFJ assembled a world-class team of KOL\u2019s as its Scientific Advisory Committee, with representation from Hong Kong, China, Japan, Europe and the US<\/li>\n
- SFJ\u2019s team led the protocol-drafting effort, with regular alignment meetings with Pfizer peers<\/li>\n<\/ul>\n
[\/vc_column_text][vc_empty_space height=”40px”][vc_column_text]<\/p>\n
Results: Several Success-Enhancing Design Changes<\/strong><\/h3>\n[\/vc_column_text][vc_empty_space height=”10px”][vc_column_text el_class=”case”]<\/p>\n
\n- Inclusion criteria adjustments<\/li>\n
- Exclusion criteria adjustments<\/li>\n
- Significant increase in the number of subjects to enhance trial powering<\/li>\n
- Operational excellence and efficiency:<\/li>\n<\/ul>\n
[\/vc_column_text][vc_empty_space height=”40px”][vc_column_text]<\/p>\n
SFJ Value-Add<\/strong><\/h3>\n[\/vc_column_text][vc_empty_space height=”20px”][vc_column_text]Within 9 months of the Co-Development Agreement closing, SFJ:[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_empty_space height=”20px”][vc_row_inner row_type=”row” type=”full_width” text_align=”left” css_animation=””][vc_column_inner][qode_elements_holder number_of_columns=”two_columns” columns_proportion=”25_75″ switch_to_one_column=”never” alignment_one_column=”left”][qode_elements_holder_item vertical_alignment=”middle” advanced_animations=”no” item_padding=”0px 20px 0px 0px”][vc_single_image image=”11208″ img_size=”150×68″ alignment=”center” qode_css_animation=””][\/qode_elements_holder_item][qode_elements_holder_item vertical_alignment=”middle” horizontal_alignment=”left” advanced_animations=”no” custom_class=”sfj-bracket-text-right”][vc_column_text el_class=”case” css=”.vc_custom_1625212707931{padding-left: 20px !important;}”]<\/p>\n
\n- Drafted the protocol and all study documents.<\/li>\n
- Completed all required regulatory meetings.<\/li>\n
- Selected a CRO<\/li>\n
- Secured the comparator drug supply<\/li>\n<\/ul>\n
[\/vc_column_text][\/qode_elements_holder_item][\/qode_elements_holder][\/vc_column_inner][\/vc_row_inner][vc_row_inner row_type=”row” type=”full_width” text_align=”left” css_animation=””][vc_column_inner][vc_empty_space height=”80px”][vc_column_text]<\/p>\n
SFJ Accelerated Recruitment Around The Globe:<\/strong><\/h2>\n[\/vc_column_text][vc_empty_space height=”10px”][vc_single_image image=”8668″ img_size=”full” qode_css_animation=””][vc_empty_space height=”40px”][vc_column_text]<\/p>\n
Efficiency From Database Lock To NDA<\/strong><\/h2>\n[\/vc_column_text][vc_empty_space height=”10px”][vc_single_image image=”8673″ img_size=”full” qode_css_animation=””][\/vc_column_inner][\/vc_row_inner][\/vc_column][vc_column width=”1\/6″][\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":"
[vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”grid” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern” css=”.vc_custom_1607690999351{background-color: #ffffff !important;}” z_index=”” padding_top=”60″ padding_bottom=”60″][vc_column width=”1\/6″][\/vc_column][vc_column width=”2\/3″][vc_row_inner row_type=”row” type=”full_width” text_align=”left” css_animation=”” css=”.vc_custom_1625004860921{padding-top: 30px !important;padding-right: 30px !important;padding-bottom: 30px !important;padding-left: 30px !important;background-image: url(https:\/\/www.sfj-pharma.com\/wp-content\/uploads\/2021\/05\/SFJ-by-the-numbers.jpg?id=8623) !important;}”][vc_column_inner][vc_column_text] SFJ Philosophy [\/vc_column_text][vc_empty_space height=”20px”][vc_column_text]SFJ\u2019s decision-making process aims at enhancing the probability of clinical and…<\/p>\n","protected":false},"author":3,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"full_width.php","meta":{"footnotes":""},"yoast_head":"\n
Case Study - SFJ Pharmaceuticals<\/title>\n\n\n\n\n\n\n\n\n\n\n\n\t\n
[\/vc_column_text][vc_empty_space height=”20px”][vc_column_text]In 2012, SFJ began a partnership with Pfizer for the funding, design, and execution of a 452-patient global Phase 3 trial of dacomitinib (Vizimpro), a first line therapy for EGFR-mutated non small cell lung cancer. Upon the success of the trial, this once-daily oral medication received regulatory approvals globally between December 2018 and May 2019.[\/vc_column_text][vc_empty_space height=”40px”][vc_column_text]<\/p>\n
Process Highlights For This Global Registration Trial:<\/strong><\/h3>\n[\/vc_column_text][vc_empty_space height=”20px”][vc_column_text css=”.vc_custom_1625212670985{padding-left: 20px !important;}”]<\/p>\n
\n- SFJ and Pfizer agreed basic study design parameters<\/li>\n
- SFJ assembled a world-class team of KOL\u2019s as its Scientific Advisory Committee, with representation from Hong Kong, China, Japan, Europe and the US<\/li>\n
- SFJ\u2019s team led the protocol-drafting effort, with regular alignment meetings with Pfizer peers<\/li>\n<\/ul>\n
[\/vc_column_text][vc_empty_space height=”40px”][vc_column_text]<\/p>\n
Results: Several Success-Enhancing Design Changes<\/strong><\/h3>\n[\/vc_column_text][vc_empty_space height=”10px”][vc_column_text el_class=”case”]<\/p>\n
\n- Inclusion criteria adjustments<\/li>\n
- Exclusion criteria adjustments<\/li>\n
- Significant increase in the number of subjects to enhance trial powering<\/li>\n
- Operational excellence and efficiency:<\/li>\n<\/ul>\n
[\/vc_column_text][vc_empty_space height=”40px”][vc_column_text]<\/p>\n
SFJ Value-Add<\/strong><\/h3>\n[\/vc_column_text][vc_empty_space height=”20px”][vc_column_text]Within 9 months of the Co-Development Agreement closing, SFJ:[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_empty_space height=”20px”][vc_row_inner row_type=”row” type=”full_width” text_align=”left” css_animation=””][vc_column_inner][qode_elements_holder number_of_columns=”two_columns” columns_proportion=”25_75″ switch_to_one_column=”never” alignment_one_column=”left”][qode_elements_holder_item vertical_alignment=”middle” advanced_animations=”no” item_padding=”0px 20px 0px 0px”][vc_single_image image=”11208″ img_size=”150×68″ alignment=”center” qode_css_animation=””][\/qode_elements_holder_item][qode_elements_holder_item vertical_alignment=”middle” horizontal_alignment=”left” advanced_animations=”no” custom_class=”sfj-bracket-text-right”][vc_column_text el_class=”case” css=”.vc_custom_1625212707931{padding-left: 20px !important;}”]<\/p>\n
\n- Drafted the protocol and all study documents.<\/li>\n
- Completed all required regulatory meetings.<\/li>\n
- Selected a CRO<\/li>\n
- Secured the comparator drug supply<\/li>\n<\/ul>\n
[\/vc_column_text][\/qode_elements_holder_item][\/qode_elements_holder][\/vc_column_inner][\/vc_row_inner][vc_row_inner row_type=”row” type=”full_width” text_align=”left” css_animation=””][vc_column_inner][vc_empty_space height=”80px”][vc_column_text]<\/p>\n
SFJ Accelerated Recruitment Around The Globe:<\/strong><\/h2>\n[\/vc_column_text][vc_empty_space height=”10px”][vc_single_image image=”8668″ img_size=”full” qode_css_animation=””][vc_empty_space height=”40px”][vc_column_text]<\/p>\n
Efficiency From Database Lock To NDA<\/strong><\/h2>\n[\/vc_column_text][vc_empty_space height=”10px”][vc_single_image image=”8673″ img_size=”full” qode_css_animation=””][\/vc_column_inner][\/vc_row_inner][\/vc_column][vc_column width=”1\/6″][\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":"
[vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”grid” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern” css=”.vc_custom_1607690999351{background-color: #ffffff !important;}” z_index=”” padding_top=”60″ padding_bottom=”60″][vc_column width=”1\/6″][\/vc_column][vc_column width=”2\/3″][vc_row_inner row_type=”row” type=”full_width” text_align=”left” css_animation=”” css=”.vc_custom_1625004860921{padding-top: 30px !important;padding-right: 30px !important;padding-bottom: 30px !important;padding-left: 30px !important;background-image: url(https:\/\/www.sfj-pharma.com\/wp-content\/uploads\/2021\/05\/SFJ-by-the-numbers.jpg?id=8623) !important;}”][vc_column_inner][vc_column_text] SFJ Philosophy [\/vc_column_text][vc_empty_space height=”20px”][vc_column_text]SFJ\u2019s decision-making process aims at enhancing the probability of clinical and…<\/p>\n","protected":false},"author":3,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"full_width.php","meta":{"footnotes":""},"yoast_head":"\n
Case Study - SFJ Pharmaceuticals<\/title>\n\n\n\n\n\n\n\n\n\n\n\n\t\n
[\/vc_column_text][vc_empty_space height=”40px”][vc_column_text]<\/p>\n
Results: Several Success-Enhancing Design Changes<\/strong><\/h3>\n[\/vc_column_text][vc_empty_space height=”10px”][vc_column_text el_class=”case”]<\/p>\n
\n- Inclusion criteria adjustments<\/li>\n
- Exclusion criteria adjustments<\/li>\n
- Significant increase in the number of subjects to enhance trial powering<\/li>\n
- Operational excellence and efficiency:<\/li>\n<\/ul>\n
[\/vc_column_text][vc_empty_space height=”40px”][vc_column_text]<\/p>\n
SFJ Value-Add<\/strong><\/h3>\n[\/vc_column_text][vc_empty_space height=”20px”][vc_column_text]Within 9 months of the Co-Development Agreement closing, SFJ:[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_empty_space height=”20px”][vc_row_inner row_type=”row” type=”full_width” text_align=”left” css_animation=””][vc_column_inner][qode_elements_holder number_of_columns=”two_columns” columns_proportion=”25_75″ switch_to_one_column=”never” alignment_one_column=”left”][qode_elements_holder_item vertical_alignment=”middle” advanced_animations=”no” item_padding=”0px 20px 0px 0px”][vc_single_image image=”11208″ img_size=”150×68″ alignment=”center” qode_css_animation=””][\/qode_elements_holder_item][qode_elements_holder_item vertical_alignment=”middle” horizontal_alignment=”left” advanced_animations=”no” custom_class=”sfj-bracket-text-right”][vc_column_text el_class=”case” css=”.vc_custom_1625212707931{padding-left: 20px !important;}”]<\/p>\n
\n- Drafted the protocol and all study documents.<\/li>\n
- Completed all required regulatory meetings.<\/li>\n
- Selected a CRO<\/li>\n
- Secured the comparator drug supply<\/li>\n<\/ul>\n
[\/vc_column_text][\/qode_elements_holder_item][\/qode_elements_holder][\/vc_column_inner][\/vc_row_inner][vc_row_inner row_type=”row” type=”full_width” text_align=”left” css_animation=””][vc_column_inner][vc_empty_space height=”80px”][vc_column_text]<\/p>\n
SFJ Accelerated Recruitment Around The Globe:<\/strong><\/h2>\n[\/vc_column_text][vc_empty_space height=”10px”][vc_single_image image=”8668″ img_size=”full” qode_css_animation=””][vc_empty_space height=”40px”][vc_column_text]<\/p>\n
Efficiency From Database Lock To NDA<\/strong><\/h2>\n[\/vc_column_text][vc_empty_space height=”10px”][vc_single_image image=”8673″ img_size=”full” qode_css_animation=””][\/vc_column_inner][\/vc_row_inner][\/vc_column][vc_column width=”1\/6″][\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":"
[vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”grid” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern” css=”.vc_custom_1607690999351{background-color: #ffffff !important;}” z_index=”” padding_top=”60″ padding_bottom=”60″][vc_column width=”1\/6″][\/vc_column][vc_column width=”2\/3″][vc_row_inner row_type=”row” type=”full_width” text_align=”left” css_animation=”” css=”.vc_custom_1625004860921{padding-top: 30px !important;padding-right: 30px !important;padding-bottom: 30px !important;padding-left: 30px !important;background-image: url(https:\/\/www.sfj-pharma.com\/wp-content\/uploads\/2021\/05\/SFJ-by-the-numbers.jpg?id=8623) !important;}”][vc_column_inner][vc_column_text] SFJ Philosophy [\/vc_column_text][vc_empty_space height=”20px”][vc_column_text]SFJ\u2019s decision-making process aims at enhancing the probability of clinical and…<\/p>\n","protected":false},"author":3,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"full_width.php","meta":{"footnotes":""},"yoast_head":"\n
Case Study - SFJ Pharmaceuticals<\/title>\n\n\n\n\n\n\n\n\n\n\n\n\t\n
[\/vc_column_text][vc_empty_space height=”40px”][vc_column_text]<\/p>\n
SFJ Value-Add<\/strong><\/h3>\n[\/vc_column_text][vc_empty_space height=”20px”][vc_column_text]Within 9 months of the Co-Development Agreement closing, SFJ:[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_empty_space height=”20px”][vc_row_inner row_type=”row” type=”full_width” text_align=”left” css_animation=””][vc_column_inner][qode_elements_holder number_of_columns=”two_columns” columns_proportion=”25_75″ switch_to_one_column=”never” alignment_one_column=”left”][qode_elements_holder_item vertical_alignment=”middle” advanced_animations=”no” item_padding=”0px 20px 0px 0px”][vc_single_image image=”11208″ img_size=”150×68″ alignment=”center” qode_css_animation=””][\/qode_elements_holder_item][qode_elements_holder_item vertical_alignment=”middle” horizontal_alignment=”left” advanced_animations=”no” custom_class=”sfj-bracket-text-right”][vc_column_text el_class=”case” css=”.vc_custom_1625212707931{padding-left: 20px !important;}”]<\/p>\n
\n- Drafted the protocol and all study documents.<\/li>\n
- Completed all required regulatory meetings.<\/li>\n
- Selected a CRO<\/li>\n
- Secured the comparator drug supply<\/li>\n<\/ul>\n
[\/vc_column_text][\/qode_elements_holder_item][\/qode_elements_holder][\/vc_column_inner][\/vc_row_inner][vc_row_inner row_type=”row” type=”full_width” text_align=”left” css_animation=””][vc_column_inner][vc_empty_space height=”80px”][vc_column_text]<\/p>\n
SFJ Accelerated Recruitment Around The Globe:<\/strong><\/h2>\n[\/vc_column_text][vc_empty_space height=”10px”][vc_single_image image=”8668″ img_size=”full” qode_css_animation=””][vc_empty_space height=”40px”][vc_column_text]<\/p>\n
Efficiency From Database Lock To NDA<\/strong><\/h2>\n[\/vc_column_text][vc_empty_space height=”10px”][vc_single_image image=”8673″ img_size=”full” qode_css_animation=””][\/vc_column_inner][\/vc_row_inner][\/vc_column][vc_column width=”1\/6″][\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":"
[vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”grid” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern” css=”.vc_custom_1607690999351{background-color: #ffffff !important;}” z_index=”” padding_top=”60″ padding_bottom=”60″][vc_column width=”1\/6″][\/vc_column][vc_column width=”2\/3″][vc_row_inner row_type=”row” type=”full_width” text_align=”left” css_animation=”” css=”.vc_custom_1625004860921{padding-top: 30px !important;padding-right: 30px !important;padding-bottom: 30px !important;padding-left: 30px !important;background-image: url(https:\/\/www.sfj-pharma.com\/wp-content\/uploads\/2021\/05\/SFJ-by-the-numbers.jpg?id=8623) !important;}”][vc_column_inner][vc_column_text] SFJ Philosophy [\/vc_column_text][vc_empty_space height=”20px”][vc_column_text]SFJ\u2019s decision-making process aims at enhancing the probability of clinical and…<\/p>\n","protected":false},"author":3,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"full_width.php","meta":{"footnotes":""},"yoast_head":"\n
Case Study - SFJ Pharmaceuticals<\/title>\n\n\n\n\n\n\n\n\n\n\n\n\t\n
[\/vc_column_text][\/qode_elements_holder_item][\/qode_elements_holder][\/vc_column_inner][\/vc_row_inner][vc_row_inner row_type=”row” type=”full_width” text_align=”left” css_animation=””][vc_column_inner][vc_empty_space height=”80px”][vc_column_text]<\/p>\n
SFJ Accelerated Recruitment Around The Globe:<\/strong><\/h2>\n[\/vc_column_text][vc_empty_space height=”10px”][vc_single_image image=”8668″ img_size=”full” qode_css_animation=””][vc_empty_space height=”40px”][vc_column_text]<\/p>\n
Efficiency From Database Lock To NDA<\/strong><\/h2>\n[\/vc_column_text][vc_empty_space height=”10px”][vc_single_image image=”8673″ img_size=”full” qode_css_animation=””][\/vc_column_inner][\/vc_row_inner][\/vc_column][vc_column width=”1\/6″][\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":"
[vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”grid” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern” css=”.vc_custom_1607690999351{background-color: #ffffff !important;}” z_index=”” padding_top=”60″ padding_bottom=”60″][vc_column width=”1\/6″][\/vc_column][vc_column width=”2\/3″][vc_row_inner row_type=”row” type=”full_width” text_align=”left” css_animation=”” css=”.vc_custom_1625004860921{padding-top: 30px !important;padding-right: 30px !important;padding-bottom: 30px !important;padding-left: 30px !important;background-image: url(https:\/\/www.sfj-pharma.com\/wp-content\/uploads\/2021\/05\/SFJ-by-the-numbers.jpg?id=8623) !important;}”][vc_column_inner][vc_column_text] SFJ Philosophy [\/vc_column_text][vc_empty_space height=”20px”][vc_column_text]SFJ\u2019s decision-making process aims at enhancing the probability of clinical and…<\/p>\n","protected":false},"author":3,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"full_width.php","meta":{"footnotes":""},"yoast_head":"\n
Case Study - SFJ Pharmaceuticals<\/title>\n\n\n\n\n\n\n\n\n\n\n\n\t\n
[\/vc_column_text][vc_empty_space height=”10px”][vc_single_image image=”8673″ img_size=”full” qode_css_animation=””][\/vc_column_inner][\/vc_row_inner][\/vc_column][vc_column width=”1\/6″][\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":"
[vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”grid” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern” css=”.vc_custom_1607690999351{background-color: #ffffff !important;}” z_index=”” padding_top=”60″ padding_bottom=”60″][vc_column width=”1\/6″][\/vc_column][vc_column width=”2\/3″][vc_row_inner row_type=”row” type=”full_width” text_align=”left” css_animation=”” css=”.vc_custom_1625004860921{padding-top: 30px !important;padding-right: 30px !important;padding-bottom: 30px !important;padding-left: 30px !important;background-image: url(https:\/\/www.sfj-pharma.com\/wp-content\/uploads\/2021\/05\/SFJ-by-the-numbers.jpg?id=8623) !important;}”][vc_column_inner][vc_column_text] SFJ Philosophy [\/vc_column_text][vc_empty_space height=”20px”][vc_column_text]SFJ\u2019s decision-making process aims at enhancing the probability of clinical and…<\/p>\n","protected":false},"author":3,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"full_width.php","meta":{"footnotes":""},"yoast_head":"\n